Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Items 501–600 of 1,001
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Lavoz, C., Rayego‐Mateos, S., Orejudo, M., Opazo-Ríos, L., Marchant, V. A., Márquez‐Expósito, L., Tejera‐Muñoz, A., Navarro‐González, J. F., Droguett, A., Ortíz, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010272 · Cited by 51
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Vidal, S., Puig, L., Carrascosa, J. M., González‐Cantero, Á., Ruiz‐Carrascosa, J., & Velasco-Pastor, A.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136740 · Cited by 48
“The IL-17 receptor (IL-17R) family comprises five receptor subunits, correlatively named IL-17RA to IL-17RE, which are not homologous to any known receptors [27].”
BackgroundMethodInfluentialPharmacological Rationale for Targeting IL-17 in Asthma
Rahmawati, S. F., Velde, M. T., Kerstjens, H. A. M., Dömling, A. S. S., Groves, M. R., & Gosens, R. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.694514 · Cited by 54
“In humans, IL-17RA gene expression has been identified in B and T lymphocytes, epithelial cells, fibroblasts, smooth muscle cells, macrophages, bone marrow stromal cells, monocytes, and vascular endothelial cells (30, 31).”
BackgroundInfluentialBimekizumab for the Treatment of Psoriasis
Freitas, E., Blauvelt, A., & Torres, T. R. (2021) · Drugs · doi:10.1007/s40265-021-01612-z · Cited by 58
“They signal through the same receptor complex (IL17RA/RC) and induce similar inflammatory gene expression in target keratinocytes [20].”
BackgroundZhang, J., Zhou, R., Deng, L., Cao, G., Zhang, Y., Xu, H., Hou, J., Ju, S., & Yang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112948 · Cited by 55
Multifaceted roles of adiponectin in rheumatoid arthritis
Liu, D., Luo, S., & Li, Z. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.08.013 · Cited by 48
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
Martile, M. D., Farini, V., Consonni, F. M., Trisciuoglio, D., Desideri, M., Valentini, E., D’Aguanno, S., Tupone, M. G., Buglioni, S., Ercolani, C., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000489 · Cited by 52
Regulatory T Cells and Inflammatory Mediators in Autoimmune Disease
Gouirand, V., Habrylo, I. B., & Rosenblum, M. D. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.010 · Cited by 54
Hưng, P. H. S., Matsubayashi, M., Tsuji, N., & Hatabu, T. (2021) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2021.110321 · Cited by 55
Suyama, K., Sakai, D., & Watanabe, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.857164 · Cited by 53
“It also induces several proinflammatory cytokines (including IL-1β, IL-6, TNFα, and CCL2), antimicrobial peptides (β-defensin), and matrix metalloproteinases (Huang et al., 2007; Gaffen, 2009; Gaffen, 2011; Amatya et al., 2017; Chen et al., 2019; Schinocca et al., 2021).”
BackgroundThe Th17/IL-17 Axis and Host Defense Against Fungal Infections
Tangye, S. G., & Puel, A. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.015 · Cited by 54
“IL-17RA-and IL-17RA-and ACT1-deficient PBMCs, unlike IL-17RC-deficient PBMCs, also failed to respond to IL17E/IL-25 110, 112, 114 , which signals through IL-17RA/IL-17RB in an ACT1-dependent manner 118 .”
Lonati, P. A., Brembilla, N. C., Montanari, E., Fontao, L., Gabrielli, A., Vettori, S., Valentini, G., Laffitte, E., Kaya, G., Meroni, P. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105008 · Cited by 53
“IL-17A and IL-17F can be secreted as disulfide-linked homo- or hetero-dimers and bind the same IL-17RA IL-17RC heterodimeric receptor [24,25].”
BackgroundThe Role of Interleukin-17A in Psoriatic Disease
Adami, S., Cavani, A., Rossi, F., & Girolomoni, G. (2014) · BioDrugs · doi:10.1007/s40259-014-0098-x · Cited by 52
“IL-17A and F have a homology of 50 % and bind the same receptor complex, but IL-17A has stronger receptor binding with greater transductional power; genetic activation responses induced by IL-17A are 10–30 times more intense than those generated by IL-17F, suggesting a more central role for IL-17A and a greater effect…”
BackgroundUpstream Stimulating Factors Regulate the Expression of RORγT in Human Lymphocytes
Ratajewski, M., Walczak‐Drzewiecka, A., Sałkowska, A., & Dastych, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200519 · Cited by 51
“This cytokine, which is also expressed by several other immune cells such as g d T cells (12) and mast cells (13), exercises its function by triggering the IL-17RA, which is ubiquitously expressed in multiple cell types (14).”
BackgroundLack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica
Zhang, Y., Huang, D., Gao, W., Yan, J., Zhou, W., Hou, X., Liu, M., Ren, C., Wang, S., & Shen, J. (2015) · International Immunology · doi:10.1093/intimm/dxv017 · Cited by 46
Regulation of group 2 innate lymphoid cells
Duerr, C. U., & Fritz, J. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.018 · Cited by 49
Butcher, M. J., Waseem, T. C., & Galkina, E. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307892 · Cited by 46
Sousa, G. R., Gomes, J. D. A. S., Damasio, M. P. S., Nunes, M. C. P., Costa, H. S., Medeiros, N. I., Fares‐Gusmao, R., Chaves, A. T., Corrêa‐Oliveira, R., & Rocha, M. O. D. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172833 · Cited by 50
“Moreover, other cells were recognized as IL-17A sources, such as monocytes, neutrophils, and natural killer T (NKT) cells [2, 3, 31].”
BackgroundThe Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease
Hayashi, Y., & Nakase, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.845078 · Cited by 53
“It thereby activates NF-κB and AP-1 signaling through NF-κB activator 1 (ACT-1) and tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF-6), respectively (Moseley et al., 2003; Gaffen, 2009; Wang et al., 2013).”
BackgroundBoudreaux, B. W., Pincelli, T., Bhullar, P. K., Patel, M. H., Brumfiel, C. M., Li, X., Heckman, M. G., Pittelkow, M. R., Mangold, A. R., & Sluzevich, J. C. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21708 · Cited by 48
The Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Robert, M., Miossec, P., & Hot, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888763 · Cited by 48
“2 IL-17 Receptor Family and Signaling Five receptors (IL-17RA to IL-17RE) compose the IL-17 receptor (IL-17R) family (32).”
BackgroundIL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.009 · Cited by 53
Antimicrobial Peptides in Gastrointestinal Inflammation
Jäger, S., Stange, E. F., & Wehkamp, J. (2010) · International Journal of Inflammation · doi:10.4061/2010/910283 · Cited by 53
“On the cytokine level, the induction is mediated by proinflammatory cytokines such as IL-1β (through NF-κB-dependent and AP-1-dependent pathways) and TNF-α [80] or IL-17 [81].”
BackgroundSustained β-Catenin Activity in Dermal Fibroblasts Is Sufficient for Skin Fibrosis
Hamburg, E. J., & Atit, R. P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.155 · Cited by 45
Corneth, O. B. J., Mus, A. M. C., Asmawidjaja, P. S., Klein Wolterink, R. G. J., van Nimwegen, M., Brem, M. D., Hofman, Y., Hendriks, R. W., & Lubberts, E. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38229 · Cited by 45
“Signaling through IL-17RA has been extensively studied, revealing the importance of the SEFIR (similar expression to fibroblast growth factor/IL-17R) domain, ACT1, and tumor necrosis factor (TNF) receptor–associated factor 6 leading to different downstream effector signaling pathways (26).”
BackgroundTh17 cytokines induce pro-fibrotic cytokines release from human eosinophils
Al‐Muhsen, S., Letuve, S., Vazquez‐Tello, A., Pureza, M. A., Al-Jahdali, H. H., BaHammam, A. S., Hamid, Q. A., & Halwani, R. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-34 · Cited by 54
“Since both IL-17A and IL-17 F share the same IL-17R receptor [46], a concentration of around 25 ng/ml or more of each IL-17 cytokine seems to be required for efficient eosinophil derived pro-fibrotic cytokine release.”
BackgroundSecukinumab for rheumatology: development and its potential place in therapy
Koenders, M., & van den Berg, W. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s105263 · Cited by 53
CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE
Simpson-Abelson, M. R., Hernández-Mir, G., Childs, E. E., Cruz, J. A., Poholek, A. C., Chattopadhyay, A., Gaffen, S. L., & McGeachy, M. J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.01.005 · Cited by 56
“The IL-17 cytokine family is the newest and least wellunderstood of the cytokine subclasses [15,16].”
Self-citationKolbinger, F., Padova, F. D., Deodhar, A. A., Hawkes, J. E., Huppertz, C., Kuiper, T., McInnes, I. B., Ritchlin, C. T., Rosmarin, D. M., Schett, G. A., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107925 · Cited by 50
Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Meehan, E. V., & Wang, K. (2022) · Genes · doi:10.3390/genes13091643 · Cited by 51
“There are five currently identified members in the IL-17 receptor family: IL-17RA, IL-17RB, IL17RC, IL-17RD, and IL-17RE [16].”
BackgroundInfluentialInterleukin-17 producing T helper cells are increased during natural Plasmodium vivax infection
Bueno, L. L., Morais, C. G., Lacerda, M., Fujiwara, R. T., & Braga, É. M. (2012) · Acta Tropica · doi:10.1016/j.actatropica.2012.02.071 · Cited by 46
Doyle, M. S., Collins, E. S., FitzGerald, O., & Pennington, S. R. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4071 · Cited by 49
Sasaki, T., Tome, S., & Takei, Y. (2020) · Molecular Brain · doi:10.1186/s13041-020-00635-z · Cited by 56
IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma Progression
Sun, Y., Pan, J., Mao, S., & Jin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114647 · Cited by 45
“The IL-17R family comprises five receptor subunits, IL-17RA-IL-17RE, which form productive receptor complexes to mediate activation of signaling in inflammatory and tumor events [24].”
BackgroundThe IL-17A/IL-17RA axis in pulmonary defence and immunopathology
Lorè, N. I., Bragonzi, A., & Cigana, C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.009 · Cited by 52
“which are ubiquitously expressed in various cell types [55].”
BackgroundInfluentialAmara, S., Alotaibi, D., & Tiriveedhi, V. (2016) · Oncology Letters · doi:10.3892/ol.2016.4713 · Cited by 47
“Typically, inflammatory cytokines induce their effect by activating inflammatory transcription factors such as the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway (9).”
Ding, Y., Ao, J., & Chen, X. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.05.014 · Cited by 44
“Although each of them shows a distinct pattern of cellular expression and 4 binds to different IL-17 receptors (IL-17Rs) including IL-17RA to IL-17RE, they have similar 5 function in promoting inflammatory responses and host defence (Gaffen, 2009; Iwakura et al., 6 2011).”
BackgroundTh17 response in patients with cervical cancer (Review)
Alves, J., Fernandes, T. A. A. D. M., de Ara�jo, J., Cobucci, R. N., Lanza, D. C. F., Bezerra, F., Andrade, V., & Fernandes, J. V. (2018) · Oncology Letters · doi:10.3892/ol.2018.9481 · Cited by 64
Saco, A., Rey-Campos, M., Rosani, U., Novoa, B., & Figueras, A. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692997 · Cited by 46
The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Self-citationInterleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
Shabgah, A. G., Amir, A., Gardanova, Z. R., Zekiy, A. O., Thangavelu, L. P., Nik, M. E., Ahmadi, M., & Navashenaq, J. G. (2021) · Cancer Medicine · doi:10.1002/cam4.4060 · Cited by 50
Liu, Y., Xie, W., Tang, Z., Tan, Z., He, Y., Luo, J., & Wang, X. (2024) · Science Advances · doi:10.1126/sciadv.adj0604 · Cited by 51
“Il17ra is a pro-inflammatory cytokine secreted by T lymphocytes and plays an important role in immune progression ( 42 , 43 ).”
BackgroundOrphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions
Mellett, M., Atzei, P., Bergin, R., Horgan, A., Floß, T., Wurst, W., Callanan, J. J., & Moynagh, P. N. (2015) · Nature Communications · doi:10.1038/ncomms7669 · Cited by 43
Immunity against a Chlamydia infection and disease may be determined by a balance of IL‐17 signaling
O’Meara, C. P., Armitage, C. W., Harvie, M., Andrew, D. W., Timms, P., Lycke, N. Y., & Beagley, K. W. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.92 · Cited by 48
IL-23/IL-17 axis in spondyloarthritis-bench to bedside
Raychaudhuri, S. P., & Raychaudhuri, S. K. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3263-4 · Cited by 46
“Among the six IL-17 isoforms, IL-17A is the most potent inflammatory cytokine [28], and its receptor IL17R is expressed ubiquitously [29].”
BackgroundDarmochwał-Kolarz, D., Michalak, M., Kolarz, B., Przegalinska-Kałamucka, M., Bojarska-Junak, A. A., Sliwa, D. A., & Oleszczuk, J. (2017) · BioMed Research International · doi:10.1155/2017/6904325 · Cited by 59
“It has also been shown that IL17 affects the maturation of dendritic cells and inhibits the response from the regulatory T cells (Treg), responsible for the phenomenon of immune tolerance [12].”
BackgroundTargeting IL-17 in psoriatic arthritis
Wang, E. A., Suzuki, É., Maverakis, E., & Adamopoulos, I. E. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2017.17037 · Cited by 52
“Additionally, alternatively spliced soluble forms of IL-17RA and IL-17RC have recently been identified and are thought to negatively regulate IL-17 signaling (21, 22).”
BackgroundSilva-Sánchez, A., & Randall, T. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00002-x · Cited by 61
“Interestingly, the IL-25 and IL-17 receptor complexes share a common subunit, the IL-17Rα [263, 264] .”
BackgroundDifferential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease
Cole, S., Manghera, A., Burns, L. A., Barrett, J., Yager, N., Rhys, H. I., Skelton, A. J., Cole, J., Goodyear, C. S., Griffiths, M., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.03.035 · Cited by 51
Casanova, J., Peel, J. N., Donadieu, J., Neehus, A., Puel, A., & Bastard, P. (2024) · Nature Immunology · doi:10.1038/s41590-024-01815-y · Cited by 43
“IL-17A, the founding and best-characterized member, and IL-17F, the molecule most closely related to it, are produced by various cells including CD4 + T (T H 17 helper T cells) cells, γδ T cells, NK T cells and group 3 innate lymphoid cells 132,133 .”
Promotion of lung tumor growth by interleukin-17
Xu, B., Guenther, J. F., Pociask, D. A., Wang, Y., Kolls, J. K., You, Z., Chandrasekar, B., Shan, B., Sullivan, D. E., & Morris, G. F. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00125.2014 · Cited by 48
“IL-17 family members bind to a family of IL-17 receptors (IL-17 receptor A to E) that form hetero- and homodimers with bound ligand to activate downstream signaling (14).”
BackgroundLavorgna, A., Matsuoka, M., & Harhaj, E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004418 · Cited by 49
Tian, A., Ma, H., Zhang, R., Tan, W., Wang, X., Bin-yang, W., Wang, J., & Wan, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141596 · Cited by 45
Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity
Lee, Y., Clinton, J., Yao, C., & Chang, S. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01172 · Cited by 43
Reis, J., Vender, R. B., & Torres, T. R. (2019) · BioDrugs · doi:10.1007/s40259-019-00361-6 · Cited by 45
Disease Resolution in Chikungunya—What Decides the Outcome?
Srivastava, P., Kumar, A., Hasan, A., Mehta, D., Kumar, R., Sharma, C., & Sunil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00695 · Cited by 50
“It has been shown that the imbalance in cytokines, such as the increase in the concentration of IL-6 along with TGF-β which results in naïve Th cells differentiating into Th17 cells (160), is a key player in arthritis and rheumatism (161).”
BackgroundChimenti, M. S., Fonti, G. L., Conigliaro, P., Triggianese, P., Bianciardi, E., Coviello, M., Lombardozzi, G., Tarantino, G., Niolu, C., Siracusano, A., et al. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-020-00322-2 · Cited by 52
“The overall effects of IL-17A produced by CNS resident cells seem to be localized [21] and not sufficient to induce depression, however it has been hypothesized that in some diseases, such as SpA, where the production of IL-17A is increased by a pathogenic sub-population of Th17 at tissue and enthesis level, making th…”
BackgroundLv, Z., Guo, M. Z., Zhao, X., Shao, Y., Zhang, W., & Li, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100047 · Cited by 46
“splendidus infection, which suggests that the AjIL-17 dimer mediates the inflammatory response starting with the binding of specific AjIL-17R complexes under conditions of pathogen infection (9, 15).”
BackgroundInterleukin-17A in lipid metabolism and atherosclerosis
Yu, X., Jiang, N., Zheng, X., Cayabyab, F. S., Tang, Z.-B., & Tang, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.012 · Cited by 42
“However, recent evidence suggests that IL-17RA alone is insufficient to mediate IL-17A signaling [3].”
BackgroundLi, Z.-Y., Dai, Y.-X., Wu, Z., Gan, L., Pu, P., Hu, C.-W., Zhou, L., Zhu, K., Shu, B., Wang, Y., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155073 · Cited by 46
Anti-IL-17 phase II data for psoriasis: A review
Brown, G. E., Malakouti, M., Wang, E., Koo, J. Y. M., & Levin, E. C. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.878448 · Cited by 45
Bosmann, M., Grailer, J. J., Russkamp, N. F., Ruemmler, R., Zetoune, F. S., Sarma, J. V., & Ward, P. A. (2013) · Shock · doi:10.1097/shk.0b013e31828f9c92 · Cited by 46
Clinical Consequences of Targeting IL-17 and TH17 in Autoimmune and Allergic Disorders
Robinson, K. M., Manni, M. L., Biswas, P. S., & Alcorn, J. F. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0361-0 · Cited by 45
IL-17RA Signaling Amplifies Antibody-Induced Arthritis
Sadik, C. D., Kim, N. D., Alekseeva, E. A., & Luster, A. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026342 · Cited by 45
“Stimulation of neutrophils with IL-17A (100 ng/ml) for 3 h, 16 h or 24 h had no effect on gene expression of IL-6, numerous chemokines, RANKL, MMP2, MMP3, MMP13, IL-1b or TNF-a (data not shown).”
BackgroundDownregulation of Chicken Interleukin-17 Receptor A during Eimeria Infection
Kim, W. H., Jeong, J., Park, A. R., Yim, D., Kim, S., Chang, H. H., Yang, S. H., Kim, D., Lillehoj, H. S., & Min, W. (2014) · Infection and Immunity · doi:10.1128/iai.02141-14 · Cited by 48
An Organismal Model for Gene Regulatory Networks in the Gut-Associated Immune Response
Buckley, K. M., & Rast, J. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01297 · Cited by 47
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection
Tosello, J., Furlan, C. L. A., Vernengo, F. F., Rodríguez, C., Ramello, M. C., Vesely, M. C. A., Serrán, M. G., Núñez, N. G., Richer, W., Piaggio, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02347 · Cited by 47
“Finally, analysis of the gene expression of molecules associated to IL-17RA signaling (6) evidenced significant differences between CD8+ T cells from infected WT and IL-17RA KO mice.”
BackgroundFTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
Gan, X., Dai, Z., Ge, C.-M., Yin, H.-Z., Wang, Y., Tan, J., Sun, S., Zhou, W., Yuan, S., & Yang, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.989353 · Cited by 41
Serum level of interleukin‐17A in patients with alopecia areata and its relationship to age
Elmorsy, E. H., Eid, A. A., Ghoneim, H., & Al‐Tameemi, K. A. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12994 · Cited by 41
Wolf, L., Sapich, S., Honecker, A., Jungnickel, C., Seiler, F., Bischoff, M., Wonnenberg, B., Herr, C., Schneider‐Daum, N., Lehr, C., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00158.2016 · Cited by 40
Roman, M., & Chiu, M. W. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s113683 · Cited by 45
Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
Cui, M., Dai, W., Kong, J., & HongZhi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.649144 · Cited by 38
“IL-17 receptors are divided into three subtypes, IL-17RA, IL-17RB, and IL-17RC, with different combinations exerting different functions (Gaffen, 2009).”
BackgroundKonermann, A., Beyer, M., Deschner, J., Allam, J., Novak, N., Winter, J., Jepsen, S. V., & Jäger, A. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.10.020 · Cited by 45
Cheng, W., Wang, X., Wu, Y., Li, W., Fu, C., Zou, L., & Zhang, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116181 · Cited by 41
Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers
Reza, M. I., & Ambhore, N. S. (2025) · Biomedicines · doi:10.3390/biomedicines13061342 · Cited by 62
“IL-17A: It interacts with its receptor complex, IL-17RA/IL-17RC, present on epithelial cells, fibroblasts, and endothelial cells, among others [76].”
Harnessing the Therapeutic Potential of Th17 Cells
Byström, J., Taher, T. E. I., Muhyaddin, M. S., Clanchy, F. I. L., Mangat, P., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/205156 · Cited by 50
“haematopoietic and nonhaematopoietic cells such as epithelial and endothelial cells [8].”
BackgroundMitchell, D., & Olive, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.004 · Cited by 38
Magyari, L., Kövesdi, E., Sarlós, P., Javorhazy, A., Sümegi, K., & Melegh, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3208 · Cited by 46
Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease
Kwon, Y.-C., Kim, J.-J., Yun, S. W., Yu, J. J., Yoon, K. L., Lee, K., Kil, H. R., Kim, G. B., Han, M.-K., Song, M. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184248 · Cited by 42
IL-17 and related cytokines involved in systemic sclerosis: Perspectives
Gonçalves, R. S. G., Pereira, M. C., Dantas, A. T., de Almeida, A. R., Marques, C. D. L., Rêgo, M. J. B. D. M., Pitta, I. D. R., Duarte, Â. L. B. P., & Pitta, M. G. D. R. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1416467 · Cited by 42
“IL17A and IL-17 F can be secreted as disulphide-bound homo- or hetero-dimers that bind to the same heterodimeric receptor IL-17RA and IL-17RC and share some functions [24,25].”
BackgroundType 3 cytokines in liver fibrosis and liver cancer
Molina, M. F., Abdelnabi, M. N., Fabre, T., & Shoukry, N. H. (2019) · Cytokine · doi:10.1016/j.cyto.2018.07.028 · Cited by 39
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
Li, H., & Tsokos, G. C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08823-4 · Cited by 48
“IL-17A, the founding member of this family, exists as either homodimers or heterodimers paired with IL-17F and is mainly produced by T helper 17 (Th17) cells [11, 12, 46], a distinct T cell subset [47].”
BackgroundSmall molecule modulators of IL-17A/IL-17RA: a patent review (2013-2021)
Zhang, B., & Dömling, A. S. S. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2143264 · Cited by 38
“The released cytokines act through their membrane-bound IL-17 receptor (IL-17R), a family of five receptors (IL17RA through IL-17RE), and activating the IL-17 signal pathway [1,2].”
Lee, Y., Ishikawa, T., Lee, H., Lee, B., Ryu, C., Mejia, I. D., Kim, M., Lu, G., Hong, Y., Feng, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.006 · Cited by 46
Immune Cells as a Source and Target of Angiogenic and Lymphangiogenic Factors
Loffredo, S., Staiano, R. I., Granata, F., Genovese, A., & Marone, G. (2013) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000353316 · Cited by 38
Zhang, B., Liu, C., Qian, W., Han, Y., Li, X., & Deng, J. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714005227 · Cited by 38
Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
Bishu, S., Su, E. W., Wilkerson, E. R., Reckley, K. A., Jones, D. M., McGeachy, M. J., Gaffen, S. L., & Levesque, M. C. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4480 · Cited by 38
“IL-17 is a proinflammatory cytokine that both induces and synergizes with tumor necrosis factor (TNF) alpha to promote induction of IL-1β and IL-6 in target cells, culminating in the production of factors such as matrix metalloproteinases and reactive oxygen species that drive erosive arthritis [3].”
BackgroundSelf-citationMurcia, R. Y., Vargas, A., & Lavoie, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154755 · Cited by 48
“Interleukin17 (IL-17) is produced by CD4 + T helper 17 and other cell types such as gamma delta T cells (γδ T), natural killer cells (NK), lymphoid tissue inducer cells (LTi), macrophages, eosinophils, and neutrophils [6, 7].”
BackgroundAberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma
Lu, T., Yu, S., Liu, Y., Yin, C., Ye, J., Liu, Z., Ma, D., & Ji, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148044 · Cited by 39
“Since their high degree of homology, IL-17A and IL-17F bind the same receptor complex which is comprised of IL-17RA and IL-17RC and consequently exhibits similar biological activities in many aspects [17, 18].”
BackgroundRitzmann, F., Jungnickel, C., Vella, G., Kamyschnikow, A., Herr, C., Li, D., Menger, M. M., Angenendt, A., Hoth, M., Lis, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46759-8 · Cited by 43
Cytokines and Their Genetic Polymorphisms Related to Periodontal Disease
Kozak, M., Dąbrowska‐Żamojcin, E., Mazurek−Mochol, M., & Pawlik, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124045 · Cited by 45
The role of interleukin‐ 1β in the immune response to contact allergens
Yeung, K., Mraz, V., Geisler, C., Skov, L., & Bonefeld, C. M. (2021) · Contact Dermatitis · doi:10.1111/cod.13955 · Cited by 43
Gastrointestinal involvement attenuates COVID-19 severity and mortalityPreprint
Livanos, A. E., Jha, D., Cossarini, F., Gonzalez-Reiche, A. S., Tokuyama, M. A., Aydillo, T., Parigi, T. L., Ramos, I., Dunleavy, K. A., Lee, B. H., et al. (2020) · medRxiv · doi:10.1101/2020.09.07.20187666 · Cited by 44
T helper 17 cells in the pathophysiology of acute and chronic kidney disease
Basile, D. P., Ullah, M. M., Collett, J. A., & Mehrotra, P. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.185 · Cited by 41
Biologics for Reducing Cardiovascular Risk in Psoriasis Patients
Terui, H., & Asano, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031162 · Cited by 41
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
Aghbash, P. S., Hemmat, N., Baradaran, B., Mokhtarzadeh, A., Poortahmasebi, V., Oskouee, M. A., & Baghi, H. B. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026776 · Cited by 41
“In addition, the Wnt pathway activates Fra1, a target of the interleukin-17 (IL17RA) cytokine cascade [63,64].”
BackgroundThe expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas
Qiu, L., He, D., Fan, X., Li, Z., Liao, C., Zhu, Y., & Wang, H. (2011) · Pituitary · doi:10.1007/s11102-011-0292-5 · Cited by 38
“IL-17R expressed in all tissues studied to date, including the pituitary tissure, IL-17 plays its role through binding to IL-17R [26–30].”
BackgroundSTAT3-Mediated IL-17 Production by Postseptic T Cells Exacerbates Viral Immunopathology of the Lung
Mukherjee, S., Allen, R., Lukacs, N. W., Kunkel, S. L., & Carson, W. F. (2012) · Shock · doi:10.1097/shk.0b013e31826f862c · Cited by 37
“As IL-17a is not thought to signal via IL-17 receptorYdependent STAT3 phosphorylation (34), the observed increase in STAT3 binding to the IL-17a promoter appears to be further evidence of the increased propensity of postseptic CD4 T cells to produce IL-17.”
BackgroundEvolution of the IL17 receptor family in chordates: a new subfamily IL17REL
Wu, B., Jin, M., Zhang, Y., Wei, T., & Bai, Z. (2011) · Immunogenetics · doi:10.1007/s00251-011-0554-4 · Cited by 43
“TRAF6 is a key adaptor protein in the human IL17Rmediated NF-κB activation, where it physically associates with IL17R or Act1 (Gaffen 2009; Rong et al. 2009).”
BackgroundInfluentialDing, Y., Ai, C., Mu, Y., Ao, J., & Chen, X. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.09.017 · Cited by 37
“addition, IL-17RA has a unique Toll/IL-1R (TIR) BB-loop (TILL) domain, localizing downstream of the SEFIR domain and potentially providing a special interaction surface for signaling molecule [3,12].”
BackgroundInfluential
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.